Published in J Clin Gastroenterol on March 01, 1999
Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol (2009) 1.16
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut (2005) 0.98
Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists. Br J Pharmacol (2013) 0.95
The evaluation of gastrointestinal function in diabetic patients. World J Gastroenterol (1999) 0.92
Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists. Br J Pharmacol (2012) 0.89
Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84
Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. Br J Pharmacol (2007) 0.82
The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients. J Korean Surg Soc (2012) 0.78
Prokinetics in the Management of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2015) 0.77
The hungry stomach: physiology, disease, and drug development opportunities. Front Pharmacol (2011) 0.76
Current issues on safety of prokinetics in critically ill patients with feed intolerance. Ther Adv Drug Saf (2011) 0.75
The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying. Br J Pharmacol (2016) 0.75
Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther (2014) 0.75
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut (2010) 3.67
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology (1992) 2.57
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek (1999) 2.14
Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology (1996) 2.14
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet (1995) 1.57
Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology (1998) 1.52
Endoscopic transmission of hepatitis B virus. Gut (1983) 1.50
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet (1999) 1.48
Gastrointestinal symptoms in Parkinson's disease. Mov Disord (1991) 1.44
Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology (1984) 1.42
Inflammatory polyps as a manifestation of intestinal graft versus host disease. Gastrointest Endosc (1993) 1.40
pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients. Gastroenterology (1987) 1.39
An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol (1996) 1.34
Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther (2012) 1.24
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17
Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol (2000) 1.17
Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care (1998) 1.12
Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther (1998) 1.11
Superior mesenteric artery thrombosis after colonoscopy. Gastrointest Endosc (1999) 1.11
Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 1.10
Symptoms and gastric function in dyspepsia--goodbye to gastroparesis? Neurogastroenterol Motil (1996) 1.08
Motility of the ileocolonic junction. Gut (1988) 1.06
Colorectal cancer screening compliance by medicine residents: perceived and actual. Am J Gastroenterol (2001) 1.05
Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol (1994) 1.05
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Dig Dis Sci (1993) 1.04
Pharmacological management of constipation. Neurogastroenterol Motil (2009) 1.04
Peptic ulcer and cancer: an examination of the relationship between chronic peptic ulcer and gastric carcinoma. Scand J Gastroenterol (1987) 1.03
Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil (2014) 1.03
Chylous ascites, intestinal lymphangiectasia and the 'yellow-nail' syndrome. Gut (1985) 1.02
The ileocecal (ileocolonic) sphincter. Z Gastroenterol (1983) 1.01
Effects of morphine and atropine on motility and transit in the human ileum. Gastroenterology (1985) 1.01
Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med (1982) 1.01
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00
Principles of applied neurogastroenterology: physiology/motility-sensation. Gut (1999) 0.99
Distinctive patterns of interdigestive motility at the canine ileocolonic junction. Gastroenterology (1984) 0.98
Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol (1994) 0.98
Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord (1997) 0.97
Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther (1995) 0.97
Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci (1996) 0.96
Gastrointestinal dysfunction in Parkinson's disease. A report of clinical experience at a single center. J Clin Gastroenterol (1994) 0.95
Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides. Dig Dis Sci (1999) 0.91
24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold? Am J Gastroenterol (1992) 0.90
Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology (1993) 0.90
Gastric emptying of liquids and solids in the portal hypertensive rat. Dig Dis Sci (1990) 0.90
Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord (1993) 0.89
Collagenous enterocolitis: a manifestation of gluten-sensitive enteropathy. J Clin Gastroenterol (1992) 0.89
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder. Dig Dis Sci (1993) 0.89
Isolation of lactobacilli with probiotic properties from the human stomach. Lett Appl Microbiol (2008) 0.88
A prospective survey of radiological bone and joint changes in primary biliary cirrhosis. Clin Radiol (1981) 0.88
Prolonged ambulatory antroduodenal manometry in humans. Am J Gastroenterol (1994) 0.87
Achalasia of the esophagus in association with renal cell carcinoma. Am J Gastroenterol (1991) 0.86
Autism and the gastrointestinal tract. Am J Gastroenterol (2000) 0.85
Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease. Liver Transpl Surg (1997) 0.85
The spectrum of functional gastrointestinal disorders in a tertiary referral clinic in Ireland. Ir J Med Sci (2011) 0.84
Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord (1995) 0.84
Antroduodenal manometry: an evaluation of an emerging methodology. Dig Dis (1997) 0.84
Response to intraluminal gas in irritable bowel syndrome. Motility versus perception. Dig Dis Sci (1995) 0.84
Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss. J Clin Pathol (1987) 0.84
Anorectal manometry in the assessment of anorectal function in Parkinson's disease: a comparison with chronic idiopathic constipation. Mov Disord (1994) 0.84
Myoelectric activity and intraluminal pressure of the canine ileocolonic sphincter. Gastroenterology (1983) 0.83
A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? Gut (2009) 0.83
The pathophysiology of diabetic gastroenteropathy: more vague than vagal. Gastroenterology (1997) 0.82
An evaluation of an ambulatory manometry system in assessment of antroduodenal motor activity. Dig Dis Sci (1996) 0.82
Major colonic hemorrhage following electrocoagulating (hot) biopsy of diminutive colonic polyps: relationship to colonic location and low-dose aspirin therapy. Gastrointest Endosc (1991) 0.82
Effect of intestinal tapering and lengthening on intestinal structure and function. Am J Surg (1995) 0.81
The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2000) 0.81
Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy. Mov Disord (1996) 0.81
Small intestinal transit in the portal hypertensive rat. Gastroenterology (1991) 0.81
Can symptoms predict esophageal motor function or acid exposure in gastroesophageal reflux disease? A comparison of esophageal manometric and twenty-four-hour pH parameters in typical and extraesophageal gastroesophageal reflux disease. J Clin Gastroenterol (2001) 0.81
Gastric myoelectrical activity and its relationship to the development of nausea and vomiting after intensive chemotherapy and autologous stem cell transplantation. Am J Gastroenterol (2001) 0.80
Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors. Dig Dis Sci (1998) 0.79
Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog. Dig Dis Sci (1996) 0.79
Achalasia of the cardia and multiple endocrine neoplasia 2B. Am J Gastroenterol (1994) 0.79
Tone of canine ileocolonic junction: topography and response to phasic contractions. Am J Physiol (1985) 0.79
Gastric compliance and motility in the portal hypertensive rat. J Invest Surg (1992) 0.79
The long-term effect of jejunoileal autotransplantation on intestinal function. Surgery (1992) 0.79
Defecatory function in Parkinson's disease: response to apomorphine. Ann Neurol (1993) 0.78
Role of the ileocecal junction in the motor response to intestinal resection. J Gastrointest Surg (1999) 0.78
Serum mediated inhibition of T-cell activation in primary biliary cirrhosis. J Clin Lab Immunol (1982) 0.78
Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy. Am J Gastroenterol (1993) 0.78
Comparative effects of intraduodenal psyllium and senna on canine small bowel motility. Aliment Pharmacol Ther (1994) 0.78
Metastatic spread of transitional cell carcinoma of the bladder to the esophagus. J Clin Gastroenterol (1998) 0.78
Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress. Dig Dis Sci (1995) 0.77
Prokinetic agents in the surgical patient. Am J Surg (1999) 0.77
The effect of intestinal autotransplantation on serum diamine oxidase activity. J Surg Res (1991) 0.77
Qualitative changes in enteric flora and short-chain fatty acids after intestinal resection. Dig Dis Sci (1998) 0.77
Enteric neuropeptide abnormalities following small bowel resection and the effect of a tapering and lengthening procedure. Transplant Proc (1996) 0.77
Luminal short-chain fatty acids and postresection intestinal adaptation. JPEN J Parenter Enteral Nutr (1997) 0.76
Anal sphincteroplasty for incontinence after ileal pouch-anal anastomosis. Report of two cases. Dis Colon Rectum (1995) 0.76
Intestinal flora and nutrient absorption after intestinal resection. J Gastrointest Surg (2006) 0.76
Adult celiac disease (celiac sprue), pernicious anemia and IgA deficiency. Case report and review of the relationships between vitamin B12 deficiency, small intestinal mucosal disease and immunoglobulin deficiency. J Clin Gastroenterol (1986) 0.76
Serum and intestinal diamine oxidase activity during intestinal adaptation. J Invest Surg (1993) 0.76
Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. Aliment Pharmacol Ther (1997) 0.76
The clinical pharmacology of motility disorders: the perils (and pearls) of prokinesia. Gastroenterology (1994) 0.76
Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides. Dig Dis Sci (1994) 0.75
Small intestinal transplantation: reflections on an evolving approach to intestinal failure. Gastroenterology (1996) 0.75
Sinusitis and gastroesophageal reflux disease. Ann Intern Med (1998) 0.75